1 study on SENOLYTIN-P1 curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
This study provides strong preclinical evidence for a novel therapeutic approach to combat brain aging and cognitive decline by targeting the FOXO4-p53 axis. The significant improvements in cognitive function and redu…
Free, no account — handy when you're working with SENOLYTIN-P1.